Anar al contingut (clic a Intro)
UdG Home UdG Home
UdG 30 anys
Tancar
Menú

Laboratori de Medicina Translacional i Ciències de la Decisió (TransLab)

Publicacions

Línia de recerca Salut digital (E-health)

Robles, N., Puigdomènech Puig, E., Gómez-Calderón, C., Saigí-Rubió, F., Cuatrecasas Cambra, G., Zamora, A., Moharra, M., Paluzié, G., Balfegó, M., & Carrion, C. Evaluation Criteria for Weight Management Apps: Validation Using a Modified Delphi Process (2020). JMIR mHealth and uHealth, 8(7), e16899. https://doi.org/10.2196/16899

Fernández-Bergés D, Degano IR, Gonzalez Fernandez R, Subirana I, Vila J, Jiménez-Navarro M, Perez-Fernandez S, Roqué M, Bayes-Genis A, Fernandez-Aviles F, Mayorga A, Bertomeu-Gonzalez V, Sanchis J, Rodríguez Esteban M, Sanchez-Hidalgo A, Sanchez-Insa E, Elorriaga A, Abu Assi E, Nuñez A, Garcia Ruiz JM, Morrondo Valdeolmillos P, Bosch-Portell D, Lekuona I, Carrillo-Lopez A, Zamora A, Vega-Hernandez B, Alameda Serrano J, Rubert C, Ruiz-Valdepeñas L, Quintas L, Rodríguez-Padial L, Vaquero J, Martinez Dolz L, Barrabes JA, Sanchez PL, Sionis A, Martí-Almor J, Elosua R, Lidon RM, Garcia-Dorado D, Marrugat J; ATHOS investigators. Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction. Open Heart. 2020 Aug;7(2):e001169. doi: 10.1136/openhrt-2019-001169. PMID: 32747454; PMCID: PMC7402007

Castells X, Ramon, Cunill R, Olivé C, Serrano D. Relationship Between Treatment Duration and Efficacy of Pharmacological Treatment for ADHD: A Meta-Analysis and Meta-Regression of 87 Randomized Controlled Clinical Trials. Journal of Attention Disorders 2020, Feb 20 doi: 10.1177/1087054720903372

Zamora A, Rivera A. Heart failure, zip code, and telemetry: a trinomial in need of understanding [Insuficiencia cardiaca, código postal, y telemetría: un trinomio con necesidad de entenderse]. Clínica e Investigación en Arteriosclerosis (English Edition). 2020;32(4):168-170. doi:10.1016/j.artere.2020.07.005

Ramos R, Masana L, Comas-Cufí M, García-Gil M, Martí-Lluch R, Ponjoan A, Plana N, Alves-Cabratosa L, Marrugat J, Elosua R, Dégano IR, Gomez-Marcos MA, Zamora A. Derivation and validation of SIDIAP-FHP score: A new risk model predicting cardiovascular disease in familial hypercholesterolemia phenotype. Atherosclerosis. 2020 Jan;292:42-51. doi: 10.1016/j.atherosclerosis.2019.10.016. Epub 2019 Oct 30. PubMed PMID: 31759248.

Puigdomenech Puig E, Robles N, Saigí-Rubió F, Zamora A, Moharra M, Paluzie G, Balfegó M, CuatrecasasCambra G, Garcia-Lorda P, Carrion C. Assessment of the Efficacy, Safety, and Effectiveness of Weight Control and Obesity Management. Mobile Health Interventions: Systematic Review. JMIR Mhealth Uhealth. 2019 Oct 25;7(10):e12612. doi: 10.2196/12612

Blanco-Silvente L, Castells X, Garre-Olmo J, Vilalta-Franch J, Saez M, Barceló MA, Capellà D. A Study of the strength of the Evidence and the Redundancy of the Research on Pharmacological Treatment for Alzheimer’s Disease: A Cumulative Meta-analysis and Trial Sequential Analysis. Eur J Clin Pharmacol 2019;75:1659-1667. DOI: 10.1007/s00228-019-02742-w

Faltinsen E, Zwi M, Castells X, Gluud C, Simonsen E, Storebø OJ. Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: a critical look. BMJ Evid Based Med. 2018 Dec 10. pii: bmjebm-2018-111110. doi:10.1136/bmjebm-2018-111110.

Castells X, Blanco-Silvente L, Cunill R. Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults. Cochrane Database Syst Rev. 2018, issue 8. https://doi.org/10.1002/14651858.CD007813.pub3

Blanco-Silvente L, Capellà D, Garre-Olmo J, Vilalta-Franch J, Castells X. Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer’s disease: Meta-analysis and meta-regression of 18 randomized clinical trials involving 5,004 patients. BMC Geriatrics 2018

Turró-Garriga O, Calvó-Perxas L, Vilalta-Franch J, Blanco-Silvente L, Castells X, Capellà D, Garre-Olmo J; Registry of Dementia of Girona Study Group (ReDeGiStudy Group). Measuring anticholinergic exposure in patients with dementia: A comparative study of nine anticholinergic risk scales. Int J GeriatrPsychiatry. 2018 May;33(5):710-717. doi: 10.1002/gps.4844.

Masana L, Zamora A, Plana N, Comas-Cufí M, Garcia-Gil M, Martí-Lluch R,

Ponjoan A, Alves-Cabratosa L, Elosua R, Marrugat J, Dégano IR, Ramos R. Incidence of Cardiovascular Disease in Patients with Familial Hypercholesterolemia Phenotype: Analysis of 5 Years Follow-Up of Real-World Data from More than 1.5 Million Patients. J Clin Med. 2019 Jul 23;8(7). pii: E1080. doi: 10.3390/jcm8071080. PubMed PMID: 31340450; PubMed Central PMCID: PMC6678686.

Dégano IR, Ramos R, García-Gil M, Zamora A, Comas-Cufí M, Francés A, Garcia-Elias A, Marrugat J. Three-year events and mortality in cardiovascular disease patients without lipid-lowering treatment. Eur J PrevCardiol. 2019 Jul:2047487319862103. doi: 10.1177/2047487319862103.

Zamora A, Masana L, Plana N, Ramos R. Estimated Percentage of Patients With Stable Coronary Heart Disease Candidates for PCSK9 Inhibitors. Response. Rev Esp Cardiol (Engl Ed). 2019 Jun;72(6):519-520. doi: 10.1016/j.rec.2018.12.009.

Vázquez-Oliva G, Zamora A, Ramos R, Subirana I, Grau M, Dégano IR, Muñoz D, Fitó M, Elosua R, Marrugat J. Analysis of Plasma Albumin, Vitamin D, and Apolipoproteins A and B as Predictive Coronary Risk Biomarkers in the REGICOR Study. Rev EspCardiol (Engl Ed). 2018 Nov;71(11):910-916. doi:10.1016/j.rec.2018.01.027.

Zamora A, Masana L, Comas-Cufi M, Plana N, Vila À, García-Gil M, Alves-Cabratosa L, Elosua R, Marrugat J, Ramos R. Number of Patients Eligible for PCSK9 Inhibitors Based on Real-world Data From 2.5 Million Patients. Rev Esp Cardiol (Engl Ed). 2018 Dec;71(12):1010-1017. doi: 10.1016/j.rec.2018.03.003.

Vázquez-Oliva G, Zamora A, Ramos R, Marti R, Subirana I, Grau M, Dégano IR, Marrugat J, Elosua R. Acute Myocardial Infarction Population Incidence and Mortality Rates, and 28-day Case-fatality in Older Adults. The REGICOR Study. Rev Esp Cardiol (Engl Ed). 2018 Sep;71(9):718-725. doi: 10.1016/j.rec.2017.10.019.

Riera M, Castells X, Tobias A, Cunill R, Blanco L, Capellà D. Discontinuation of Pharmacological Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder: Meta-analysis of 63 Studies Enrolling 11,788 patients. Psychopharmacology (Berl) 2017; 234: 2657–2671

Blanco-Silvente L, Castells X, Saez M, Barceló MA, Garre-Olmo J, Vilalta-Franch J, Capellà D. Discontinuation, efficacy and safety of cholinesterase inhibitors for Alzheimer’s disease: a meta-analysis and meta-regression of 44 randomized clinical trials enrolling 16,245 patients. Int J Neuropsychopharmacol. 2017 Feb 13. doi: 10.1093/ijnp/pyx012.

Giner-Soriano M, Roso-Llorach A, Vedia Urgell C, Castells X, Capellà D, Ferreira-González I, Elorza JM, Casajuana M, Troncoso Mariño A, Diògene E, Bolíbar B, Violan C, Morros R. Effectiveness and safety of drugs used for stroke prevention in a cohort of non-valvular atrial fibrillation patients from a Primary Care electronic database. Pharmacoepidemiol Drug Saf 2017;26:97-107

Dégano IR, Marrugat J, Grau M, Salvador-González B, Ramos R, Zamora A, Martí R, Elosua R. The association between education and cardiovascular disease incidence is mediated by hypertension, diabetes, and body mass index. Sci Rep. 2017 Sep 28;7(1):12370. doi: 10.1038/s41598-017-10775-3.

Zamora A, Masana L, Comas-Cufí M, Vila À, Plana N, García-Gil M, Alves-Cabratosa L, Marrugat J, Roman I, Ramos R; XULA and ISV-Girona groups. Familial hypercholesterolemia in a European Mediterranean population-Prevalence and clinical data from 2.5 million primary care patients. J ClinLipidol. 2017 Jul - Aug;11(4):1013-1022. doi: 10.1016/j.jacl.2017.05.012.

Masana L, Ros E, Sudano I, Angoulvant D; lifestyle expert working group. Is there a role for lifestyle changes in cardiovascular prevention? What, when and how? Atheroscler Suppl. 2017 Apr;26:2-15. doi: 10.1016/S1567-5688(17)30020-X.

Castells X, Cunill R, Pérez-Mañá C, Capellà D. Psychostimulant drugs for cocaine dependence. Cochrane Database of Systematic Reviews, 2016, Issue 9, CD007380

Giner-Soriano M, Vedia Urgell C, Roso-Llorach A, Morros R, Capellà D, Castells X, Ferreira-González I, Troncoso Mariño A, Diògene E, Elorza JM, Casajuana M, Bolíbar B, Violan C. Effectiveness, safety and costs of thromboembolic prevention in patients with non-valvular atrial fibrillation: phase I ESC-FA protocol study and baseline characteristics of a cohort from a primary care electronic database. BMJ Open. 2016;6:e010144. doi: 10.1136/bmjopen-2015-010144

Cunill R, Castells X, Tobias A, Capellà D. Efficacy, safety andvariability in pharmacotherapy for adults withattentiondeficithyperactivitydisorder: a meta-analysisand meta-regression in over 9000 patients. Psychopharmacology (Berl). 2016;233:187-97

Zamora A, Carrion C, Vázquez-Oliva G, Paluzie G, Martín-Urda A, Elosua R. Theoretical impact on coronary disease of using a computerized clinical decision support system in the prescription of lipid-lowering treatment. Rev Esp Cardiol (Engl Ed). 2015 Jan;68(1):75-8. doi: 10.1016/j.rec.2014.08.006. Epub 2014 Dec 4. PubMed PMID: 25482341

Cunill R, Castells X, Tobias A, Capellà D. Pharmacological Treatment of Attention Deficit Hyperactivity Disorder with Co-morbid Drug Dependence. J Psychopharmacol 2015;29:15-23

Escull quins tipus de galetes acceptes que el web de la Universitat de Girona pugui guardar en el teu navegador.

Les imprescindibles per facilitar la vostra connexió. No hi ha opció d'inhabilitar-les, atès que són les necessàries pel funcionament del lloc web.

Permeten recordar les vostres opcions (per exemple llengua o regió des de la qual accediu), per tal de proporcionar-vos serveis avançats.

Proporcionen informació estadística i permeten millorar els serveis. Utilitzem cookies de Google Analytics que podeu desactivar instal·lant-vos aquest plugin.

Per a oferir continguts publicitaris relacionats amb els interessos de l'usuari, bé directament, bé per mitjà de tercers (“adservers”). Cal activar-les si vols veure els vídeos de Youtube incrustats en el web de la Universitat de Girona.